Stand out for this role — generate a tailored resume and cover letter in about a minute.
Samphire Neuroscience is seeking a driven professional to start in clinical partnership development and advance to ownership of the US commercial launch for non-invasive neuromodulation devices. This role focuses on building partnerships, defining pilots, and navigating 510(k) and de novo clearance strategies from day one.
Based in the US (California preferred), you will recruit Frontier Clinical Partners, track pilot metrics, build payer relationships, and help scale the commercial footprint
We are building non-invasive neuromodulation devices for conditions like PMDD, endometriosis, chronic pelvic pain, and migraine — conditions that hormonal and surgical approaches have consistently underserved. Our PMDD 510(k) and endometriosis de novo pathways are active. CREST26, our pivotal US trial, is underway.
This role starts in clinical partnership development and evolves into full ownership of US commercial launch. It is a role for someone energised by the generative, early phase who has the commercial credibility to execute what comes after it.
This is a full-time or part-time position, US-based (California preferred).
Email your CV or LinkedIn profile and a short note on why this role interests you to careers@samphireneuro.com and em@samphireneuro.com.
Like the look of this role? We’d love to hear from you.